Dan Dearborn - Oct 18, 2024 Form 3 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Chief Financial Officer
Signature
/s/ Dan Dearborn
Stock symbol
KTRA
Transactions as of
Oct 18, 2024
Transactions value $
$0
Form type
3
Date filed
10/22/2024, 07:56 PM
Next filing
Nov 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KTRA Common Stock 0 Oct 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 is being filed solely to reflect the reporting person becoming a director, officer or 10% owner of TuHURA Biosciences, Inc.

Remarks:

See Exhibit 24 - Power of Attorney.